Related Experiment Video
Updated: May 16, 2026
10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Therapeutic approaches for lysosomal storage diseases
Therapeutic Advances in Endocrinology and Metabolism
|November 14, 2012
Summary
Lysosomal storage disorders (LSDs) are metabolic diseases causing tissue buildup. Current therapies face challenges, especially for central nervous system (CNS) involvement due to the blood-brain barrier.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Lysosomal storage disorders (LSDs) are a group of inherited metabolic diseases.
- Characterized by the accumulation of undegraded substrates within lysosomes.
- Caused by enzyme deficiencies essential for cellular waste breakdown.
Purpose of the Study:
- To review the current understanding of LSDs, including their pathogenesis and therapeutic strategies.
- To highlight the challenges in treating LSDs, particularly central nervous system (CNS) manifestations.
- To discuss emerging therapeutic approaches for LSDs.
Main Methods:
- Review of existing literature on lysosomal storage disorders.
- Analysis of current therapeutic interventions and their limitations.
- Exploration of novel treatment strategies and delivery methods.
Main Results:
- LSDs affect multiple organs due to substrate deposition.
- Inflammation, apoptosis, and autophagy defects contribute to organ dysfunction.
- Hematopoietic stem cell transplantation, enzyme replacement, and substrate reduction are established therapies.
- Pharmacological chaperones and gene therapy are under investigation.
- CNS involvement is common but difficult to treat due to the blood-brain barrier.
Conclusions:
- LSDs represent a significant challenge in metabolic medicine.
- Targeting CNS manifestations requires overcoming the blood-brain barrier.
- Advancements in understanding disease mechanisms will drive new therapeutic development for LSDs.
- Future strategies will focus on delivering therapies to affected tissues like the brain, bones, and lungs.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:31Lysosomes
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
01:31Lysosomes
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...